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Rat-liver mitochondriaBesides triiodothyronine (T3), 3,5-diiodo-L-thyronine (T2) has been reported to affect mitochondrial
bioenergetic parameters. T2 effects have been considered as independent of protein synthesis. Here, we
investigated the effect of in vivo chronic T2 administration to hypothyroid rats on liver mitochondrial FoF1-
ATP synthase activity and expression. T2 increased state 4 and state 3 oxygen consumption and raised ATP
synthesis and hydrolysis, which were reduced in hypothyroid rats. Immunoblotting analysis showed that T2
up-regulated the expression of several subunits (α, β, FoI-PVP and OSCP) of the ATP synthase. The observed
increase of β-subunit mRNA accumulation suggested a T2-mediated nuclear effect. Then, the molecular basis
underlying T2 effects was investigated. Our results support the notion that the β-subunit of ATP synthase is
indirectly regulated by T2 through, at least in part, the activation of the transcription factor GA-binding
protein/nuclear respiratory factor-2. These ﬁndings provide new insights into the T2 role on bioenergetic
mechanisms.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Thyroxine (T4), the major iodothyronine secreted by the thyroid
gland, is metabolized through outer ring deiodination by a deiodinase
enzyme [1] to the 3,5,3′-triiodo-L-thyronine (T3), which has several
effects on growth, development and metabolism. Until recently, T3 was
generally assumed to be the most active iodothyronine, and T4 its
precursor. However, a growing body of evidence indicates that other
iodothyronines, in particular 3,5-diiodo-L-thyronine (T2), produced by
peripheral deiodination of T3, exhibit important biological effects [2–5].
Mitochondria, given their biochemical functions, are natural candidates
as a target for the effects of thyroid hormones (THs) [6–9]. THs may
inﬂuence mitochondrial activity either indirectly or directly by
interaction with nuclear receptors and with the mitochondrial energy
apparatus [10]. Evidence has been presented indicating that T2,bovine serum albumin; ChIP,
chondrial particles; FT3, free
owth hormone; IOP, iopanoic
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ll rights reserved.previously considered only as a T3 catabolite, is able to mimic effects
of T3 on energy metabolism. Several reports showed that T2 adminis-
tration to rats resulted in signiﬁcant changes in mitochondrial activity.
T2 action appeared to bemore rapid than T3 effect [3,5,7,11,12].While T3
is generally considered to play genomic actions [3], many laboratories
have demonstrated T2 metabolic effects independent of protein
synthesis [4,5,7,13,14]. It has been shown that T2 effects can be
mediated by T2 binding to a speciﬁc mitochondrial site [15]. Subunit
Va of cytochrome oxidase (COX) has been identiﬁed as a binding site for
T2 [16].
FoF1-ATP synthase, the mitochondrial complex V responsible for
ATP synthesis, is composed of three parts: the catalytic sector F1,
consisting of ﬁve subunits (3α; 3β; γ; δ; ɛ), the H+ translocating
sector Fo and a stalk connecting F1 with Fo, both consisting of a
variable number of subunits [17,18]. In the FoF1–ATP synthase
complex, in addition to the F1-γ and the FoI-PVP(b) subunits [17],
also the oligomycin-sensitivity-conferring protein (OSCP) is involved
in the coupling of the F1 catalytic activity to transmembrane proton
translocation by Fo [19]. It has been shown that the FoF1-ATP synthase
represents one of the sites of T3 action [20,21].
However, studies on T2 effects on this complex are lacking. The
present study represents the ﬁrst evidence that chronic T2 adminis-
tration to hypothyroid rats raises FoF1-ATP synthase activity in both
ATP synthesis and hydrolysis direction. Interestingly, an increase of
both mRNA and protein levels of FoF1-ATP synthase subunits were
observed, thus suggesting a T2-induced nuclear effect. To study the
234 R. Mangiullo et al. / Biochimica et Biophysica Acta 1797 (2010) 233–240molecular basis of these observations, the effect of T2 administration
on the expression of GA-binding protein/nuclear respiratory factor-2
α-subunit (NRF-2α), one of the nuclear respiratory factors suggested
to coordinate expression of the nuclear and mitochondrial genomes
[22], was analysed.
2. Materials and methods
2.1. Chemicals
Oligomycin, 6-n-propyl-2-thiouracil (PTU), iopanoic acid (IOP), T2
(more than 99% pure) and all other reagents were from Sigma-
Aldrich. RPAIII kit was from Ambion. SYBR Green was from FluoCycle,
Euroclone.
2.2. Animal treatment
Male Wistar rats (200–250 g) were housed in individual cages in a
temperature-(22±1 °C) and light-(light on 08:00 h–20:00 h) controlled
room. T2 and IOPwere dissolved in 0.05MNaOH and dilutedwith 0.09%
NaCl. The rats were divided into three groups. Group 1, representing
euthyroid control rats, was treated with only vehicle for 4 weeks; group
2, rats were made hypothyroid by continuous administration of PTU
(0.1%w/v, in drinking tapwater) for 4weeks togetherwith aweekly i.p.
injection of IOP (6mg/100 g b.w.); group 3, ratsweremade hypothyroid
as group 2 but received during the last week a daily i.p. injection of T2
(15 μg/100 g b.w.) (hypothyroid+T2). No signiﬁcant change in food
intake, liver and body weight was observed in T2-treated rats relative to
hypothyroid rats (data not shown).
The experimental designwas in accordancewith local and national
guidelines regarding animal experiments.
To determine serum levels of THs, blood was collected from rats
and free T3 (FT3) and free T4 (FT4) were determined as in [23].
2.3. Isolation of mitochondria and preparation of sub-mitochondrial
particles
Rat-liver mitochondria were prepared following standard
procedures.
Inside-out sub-mitochondrial particles were prepared in the
presence of EDTA (ESMP) by exposure of mitochondria to ultrasonic
energy [24].
Protein concentration was determined by using the Bradford
BioRad protein assay and bovine serum albumin (BSA) as a standard.
2.4. Mitochondrial respiration
Mitochondrial respiration (0.3 mg of mitochondrial protein/mL)
wasmeasured in a medium consisting of 220mM sucrose, 20mMKCl,
2.5 mM KH2PO4, 1 mM EDTA, 20 mM Hepes, 5 mM MgCl2, 2 μg/mL
rotenone, 0.1% BSA (fraction V, fatty acid-free from Sigma) and 5 mM
K-succinate, pH 7.4, by a Clark oxygen electrode at 25 °C. This
temperature, even if non-physiological for mammals, shows a
reduced contribution of proton leak to basal respiration and is closed
to thermoneutrality for rats [25,26]. State 3 respiration was initiated
by the addition of 0.3 mM MgADP and followed until total
consumption of ADP when state 4 respiration was measured. Then,
4 mM CCCP was added to measure uncoupled respiration. State 3,
state 4 and uncoupled respiration, respiratory control index (RCI) and
ADP/O ratio were calculated as in [27].
2.5. ATP synthase and hydrolase activity
The rate ofmitochondrial ATP synthesis was determined on freshly
isolated mitochondria [21]. Oligomycin-sensitive ATP hydrolase
activity of ESMPwasmeasured with an ATP-regenerating system [24].2.6. Probe design
ATP synthase β subunit cDNA was ampliﬁed by reverse transcriptase
PCR using rat-liver total RNA as template and the following primers:
forward 5′-CTGCAGAATTCAGAGATGAGTGTTGAACAGG-3′ and reverse
5′-AAGCTTTACAGAATAACCACCATGGG-3′ (GenBank™accessionnumber
NM_134364), containing respectively an EcoRI and HindIII sites (under-
lined), added for subcloning purposes. The ampliﬁed product (174 bp)
was subcloned, sequenced andused in the in vitro transcription reactions.
2.7. RNase protection assay (RPA)
mRNA level was investigated by RPA (RPAIII™, Ambion). To this
end, antisense RNA was synthesized by an in vitro transcription
reaction [28]. Total RNA (10 μg), extracted from rat liver [23], was
hybridized with 2×105 cpm (∼2 fmol, 1.7×109 cpm/μg) of 32P-
labeled speciﬁc antisense probe in 20 μL of hybridization reaction at
50 °C for 16 h. For the normalization, a 2×103 cpm of antisense 32P-
labeled 28S rRNA probe was added in each hybridization reaction.
Pilot experiments with constant amount of probes but different
concentrations of RNA conﬁrmed that the concentration of probes
was in molar excess. As a control for testing the RNase activity, the
probe was also hybridized with 10 μg of yeast RNA (not shown). After
digestion with RNase A/T1, the protected fragments were separated
onto 6% denaturing polyacrylamide gel. Gels were dried, exposed to
Hyperﬁlm for autoradiography and the intensity of the bands was
evaluated by densitometry with Molecular Analyst software (BioRad).
2.8. Quantitative RT-PCR analysis
Reverse transcriptase reaction (20 μL) was carried out using 5 μg of
total RNA, 100 ng of random hexamers and 200 U SuperScript™ III
RNase H-Reverse transcriptase. Quantitative gene expression analysis
was performed using SYBR Green technology and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) mRNA for normalization. The
primers used for real time PCR analysis were the following: NRF-2α
forward 5′-AGACAGAAGCCAAACAGGAG-3′, NRF-2α reverse 5′-
TGTTCCACAATGCTTTCTTC-3′ (GenBank™ accession number
NM_001108841), β-F1 forward 5′-AGAGATGAGTGTTGAACAGG-3′ and
β-F1 reverse 5′-TACAGAATAACCACCATGGG-3′ (GenBank™ accession
number NM_134364); GAPDH forward 5′-GCATGGCCTTCCGTGTTCC-
TACC-3′, GAPDH reverse 5′-GCCGCCTGCTTCACCACCTTCT-3′ (Gen-
Bank™ accession number NM_017008.3).
2.9. Isolation of total proteins from liver
Total proteins from liver were obtained by homogenizing a piece of
rat liver (about 0.5 g) in amediumcontaining 210mMmannitol, 70mM
sucrose, 1 mM EDTA, 5 mM Tris/HCl pH 7.5 plus protease inhibitors.
2.10. Electrophoresis and immunoblotting procedures
Proteins were separated on 15% (for mitochondrial proteins) or
10% (for total proteins from liver) SDS-PAGE gels [23]. The separated
proteins were transferred to nitrocellulose membranes and incubated
with primary antibodies all diluted in 20 mM Tris/HCl, pH 7.6, 0.14M
NaCl, 0.5% Tween 20 (TBS-T). After washing with TBS-T, the
membranes were incubated with HRP-conjugated secondary anti-
bodies (Pierce) which were visualized using the chemiluminescence
kit (GE Healthcare). The blots were then exposed to Hyperﬁlm and
signals were quantiﬁed by densitometry as for RPA.
2.11. Chromatin immunoprecipitation (ChIP) assay
The ChIP assay was performed as in [29]. Chromatin complexes
were immunoprecipitated for 12–18 h at 4 °C with 10 μg of anti-NRF-
Table 1
Effect of 3,5-diiodothyronine on rat-liver mitochondrial respiratory rates.
Rats State 4 State 3 CCCP-
stimulated
RCI ADP/O
Euthyroid 18.9±1.5a 125.0±6.7a 186±7.5a 6.6±0.8 1.3±0.10a
Hypothyroid 9.4±1.6b 68.5±9.6b 136±6.5b 7.3±0.9 1.7±0.05b
Hypothyroid+T2 20.1±2.3a 132.8±10.1a 199±11.5a 6.6±1.5 1.3±0.15a
Succinate-dependent oxygen consumption was measured by a Clark oxygen electrode.
Respiratory rates are expressed as natoms oxygen min− 1 mg of mitochondrial
protein−1. Data represent the means ± SE of 6 different experiments performed with
duplicate samples. Values sharing a different letter differ signiﬁcantly. RCI: respiratory
control index.
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overnight at 4 °C on a rotating wheel. After immunoprecipitation
performed as in [30] with non-speciﬁc IgGs or with antibody against
NRF-2α, initial PCRs were conducted with serial dilutions of input
material from each immunoprecipitation to establish the appropriate
cycling conditions and accurately compare template content across
treatments (not shown). Primers were designed to amplify a 486 bp
fragment (−503/−17 bp upstream the ATG translation initiation
codon) of the proximal promoter region in the rat β-F1 gene. Primer
sequences used in PCR reaction were the following: β-F1ChIP forward
(5′-TAAAGACCCTCCAGGTTTCC-3′) and β-F1ChIP Reverse (5′-GACT-
GAGCGCTCCAGCGGTC-3′). The PCR reaction was performed with 2 μL
of immunoprecipitate, in a ﬁnal volume of 25 μL, 100 nMof each primer,
and 1 × PCR mix (Sigma) in a Thermal Cycler (Applied Biosystem).
Samples were incubated for an initial denaturation at 94 °C for 60 s,
followed by 30 cycles at 94 °C for 20 s, 62 °C for 20 s, and 72 °C for 30 s.
PCR products were separated on a 1.5% (w/v) agarose gel and analysed
by ethidium bromide staining. The stained gel was visualized and the
PCRproducts fromthree individual experimentswerequantiﬁedusinga
Versadoc imaging system (Bio-Rad Laboratories).
2.12. Reporter vector construction and transient transfection assay
The DNA fragment (486 bp) of rat ATP synthase β-F1 promoter was
obtained by PCR using a rat genomic DNA as template and the primers
forward 5′-GAATTCGGTACCTAAAGACCCTCCAGGTTTCC-3′ and re-
verse 5′-GAATTCCTCGAGACTGAGCGCTCCAGCGGTC-3′, located at
503 bp and 37 bp, respectively, upstream the ATG codon. The am-
pliﬁcation product was digested with KpnI and XhoI, then subcloned
into the same sites of pGL3 basic vector (Promega), obtaining the
pATP5B486 construct. Rat hepatoma cell line H4IIE was maintained in
Dulbecco's modiﬁed Eagle's medium (Sigma) supplemented with 10%
(v/v) fetal bovine serum (FBS), penicillin G (100 units/mL) and
streptomycin (100 μg/mL) at 37 °C under 5% CO2 atmosphere.
Transfection and luciferase assays were carried out as described in
[30]. H4IIE cells were co-transfected with pATP5B486 (1.5 μg/well)
and the Renilla luciferase reference plasmid, pGL4.73 (0.02 μg/well),
control for transfection efﬁciency, by using FuGENE 6 transfection
reagent (Roche Diagnostics); then, the cells were incubated for 24 h.
After transfection, to evaluate the effect of T2 on rat β-F1 promoter
activity, cells were incubated in DMEM medium supplemented with
10% (v/v) charcoal-treated FBS and 10−7 M T2. For transcriptional
activation by NRF-2α, H4IIE cells were transiently co-transfected with
p503ATP5B and pGL4.73 reference plasmid as described above,
together with either pCMV-NRF2α (Geneservice, United Kingdom)
(0.1 μg/well) encoding the NRF-2α transcription factor, or pcDNA3.1
control empty vector.
2.13. Statistical analysis
Data are means±standard error (SE) of the indicated number of
experiments. The results were computed with Excel (Microsoft).
Comparison was made using one way analysis of variance (ANOVA)
followed by a post-hoc Tukey's B test. All statistical analyses were
performed using SPSS/PC computer program. In all instances Pb0.05
was taken as the lowest level of signiﬁcance.
3. Results
3.1. Thyroid state of treated rats
In hypothyroid rats the serum level of FT3 decreased by 62%
(1.32±0.35 vs. 3.42±0.61 pmol/L of euthyroid, n=5) and FT4 level
by about 90% (0.21±0.05 vs. 2.93±0.33 μg/dL of euthyroid, n=5).
The reduction in FT3 and FT4 levels in the hypothyroid rats conﬁrmed
the effectiveness of treatment with PTU plus IOP in inducing a severehypothyroid status [14]. Notably, chronic T2 administration to
hypothyroid rats did not signiﬁcantly affect either FT3 [14] and FT4
serum levels (data not shown).
3.2. Effect of T2 on mitochondrial respiratory rates and ADP/O ratio
Consistent with previous data [21] state 4 and state 3 oxygen
consumption was reduced (∼ 50%) in mitochondria from hypothyroid
as compared to euthyroid rats (Table 1). A signiﬁcant decrease (∼30%)
in CCCP-induced uncoupled respiration was also observed in
mitochondria from hypothyroid rats. Treatment of hypothyroid rats
with T2 signiﬁcantly increased respiratory rates in state 4, state 3 and
uncoupled state, restoring rates to those of euthyroid rats.
The level of coupling between the phosphorylation activity and the
mitochondrial respiration is represented by ADP/O ratio. This
parameter signiﬁcantly increased in hypothyroid in comparison to
control animals while it was almost unaffected in hypothyroid+T2.
However, no signiﬁcant variation was observed in RCI values between
the different groups of rats, thus indicating that the quality of
mitochondrial preparations from control and treated rats was similar
[31].
3.3. T2 effect on the ATP synthase activity
The observed changes in respiratory rate in T2-treated hypothy-
roid rats could reﬂect changes in the activity of oxidative phosphor-
ylation. Therefore, the rate of ATP synthesis was investigated. ATP
synthesis was signiﬁcantly reduced (−34%) in succinate-supplemen-
ted mitochondria from liver of hypothyroid as compared to euthyroid
rats (Fig. 1A). T2 administration to hypothyroid rats restored ATP
synthesis to the level observed in euthyroid rats.
To verify whether the increased ATP synthesis observed upon T2
treatment could be ascribed to a direct effect of the hormone on FoF1-
ATP synthase, we measured oligomycin-sensitive ATP hydrolase
activity in ESMP, as this activity does not depend on the other
respiratory chain components [21]. Moreover, ESMP should permit to
study the effects of T2 on ATP synthase, differentiating them from the
effects on adenine nucleotide translocator or adenine nucleotide
content [20]. Fig. 1B shows a decrease (−36%) of the oligomycin-
sensitive ATP hydrolase activity in ESMP from hypothyroid compared
to ESMP from euthyroid rats. ATP hydrolase activity in ESMP from
hypothyroid+T2 showed a recovery to the value seen in euthyroid
rats (Fig. 1B).
3.4. T2 effect on transcription and translation of ATP synthase
The catalytic β-F1 subunit of the FoF1-ATP synthase is encoded,
unlike other components of oxidative phosphorylation complexes
[21], by a single copy gene [32], ubiquitously expressed inmammalian
cells. The ATP synthase β-F1 represents a nuclear gene encoding for a
mitochondrial innermembrane protein known to respond to THs [22].
In order to study the molecular events possibly responsible for the
observed changes in FoF1-ATP synthase activity, the levels of β-F1
Fig. 2. β-subunit mRNA abundance in rat liver of T2-treated hypothyroid rats. Total liver
RNA (10 μg) was hybridized with 32P-labeled β-subunit and 28S rRNA (used for the
normalization) antisense probes. The bars represent the optical scan of the
autoradiogram. The data are expressed as percentage of β-subunit abundance of
euthyroid rats (100 %) and are means±SE of 4 different experiments. Values sharing a
different letter differ signiﬁcantly.Fig. 1. FoF1-ATP synthase activity in rat-liver mitochondria and submitochondrial
particles of T2-treated hypothyroid rats. (A) ATP synthesis was measured on freshly
isolated rat-liver mitochondria. Data represent the means±SE of 6 different
experiments performed with duplicate samples. (B) Sub-mitochondrial particles
were prepared in the presence of EDTA (ESMP) and oligomycin-sensitive ATP
hydrolysis was measured with ATP 1 mM using an ATP-regenerating system. Data
represent themeans±SE of 5 different experiments performedwith duplicate samples.
Values sharing a different letter differ signiﬁcantly.
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Using a β-F1 probe, it was found that the amount of protected β-F1
mRNA decreased (−30%) in hypothyroid relative to euthyroid rats
(Fig. 2). Interestingly, treatment of hypothyroid rats with T2, which is
generally believed to operate by a non-nuclear mechanism [reviewed
in 5], restored the β-F1 mRNA content to euthyroid levels. In
accordance with a previous report [21], T3, administered under the
same experimental conditions of T2, signiﬁcantly increased the level
of ATP synthase β-subunit mRNA (data not shown). The amount of
28S rRNA, used for normalization, was unmodiﬁed.
In order to verify whether the changes in β-F1 mRNA level were
associated with modiﬁcation in the protein content, western blot
analysis of α/β subunits of ATP synthase was performed. Fig. 3A
shows that the immunodetected α/β proteins decreased (−40%) in
hypothyroid mitochondria, whereas they were raised by T2 to the
level of the euthyroid control.
The levels of FoI-PVP and OSCP, two stalk subunits necessary for
the correct functioning of ATP synthase [19] were also analyzed. As
obtained for α/β, the content of FoI-PVP and OSCP subunits
markedly decreased in hypothyroid rats and was restored to
euthyroid levels by T2 treatment (Fig. 3A and B). Porin was used
for normalization (Fig. 3) as its amount is unmodiﬁed upon thyroid
hormone treatment [23].
3.5. T2 increases NRF-2α mRNA abundance and protein level in liver
from hypothyroid rats
GA-binding protein/nuclear respiratory factor-2, belonging to ETS
transcription factor family, is an ubiquitously expressed nuclear
transcription factor involved in a broad range of cellular processes,such as the activation of some nuclear genes encoding for mitochon-
drial proteins [33–35].
To acquire further insight into the mechanism by which T2
increases transcription of β-F1 gene, NRF-2α mRNA and protein
levels were quantiﬁed in rat liver. T2 administration to hypothyroid
rats increased (about 38%) NRF-2αmRNA abundancewhen compared
to hypothyroid animals (Fig. 4A). Similarly to mRNA, the NRF-2α
protein level also augmented (Fig. 4B) following T2 treatment. Protein
disulphide-isomerase (PDI) was used for normalization since its
amount is not affected in rat liver by the thyroid state [22].
In order to evaluate whether T2 effect on NRF-2α and β-F1 gene
expression was evident already after short time T2 treatment, a time
course analysis of NRF-2α and β-F1 mRNA level was carried out.
Hypothyroid rats were treated with a single T2 dose and liver from
individual rats was dissected at various times after hormone injection.
Increase of NRF-2α mRNA abundance was already evident after
30 min, reaching the maximum 1 h after T2 administration (Fig. 4C).
Augmentation of β-F1 mRNA level was also observed, being evident
after 1 h and reached the maximum at 8 h (Fig. 4C). These data
indicated that the NRF-2α induction preceded that of β-F1 subunit,
suggesting that NRF-2 might be involved in the control of this gene
exerted by T2.
3.6. Speciﬁc binding in vivo of NRF-2α to β-F1 promoter
To investigate whether NRF-2α binding to the proximal promoter
of the endogenous β-F1 gene is in vivo modulated by T2, a ChIP assay
was performed. Chromatin from liver of euthyroid, hypothyroid and
T2-treated hypothyroid rats was isolated. After immunoprecipitation
with antibodies against NRF-2α, or with non-speciﬁc IgGs, PCRs were
carried out. A 486 -bp fragment of the proximal β-F1 promoter was
ampliﬁed only when immunoprecipitation was performed with
speciﬁc anti-NRF-2α antibody (Fig. 4D). By contrast, amplimers
were not detected in immunoprecipitation experiments performed
with non-speciﬁc IgGs (data not shown). In T2-treated rats the
Fig. 3. Effect of T2 treatment on the expression of α/β, FoI-PVP and OSCP subunits of ATP synthase in rat-liver mitochondria. Liver-mitochondrial proteins (15 μg), isolated from
different rat groups, were separated by electrophoresis and transferred onto nitrocellulose membranes. The latter were incubated with antibodies against α/β, FoI-PVP and OSCP
subunits of ATP synthase. Panel A shows a representative experiment. Panel B shows the histograms representing themeans ± SE of the values obtained from densitometric analysis
of 6 different experiments after normalization with porin. The data are expressed as percentage of the protein level of euthyroid rats (100 %). Values sharing a different letter differ
signiﬁcantly.
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compared with the control.
3.7. T2 treatment and NRF-2α overexpression activate the β-F1 promoter
activity
To investigate the effect of T2 treatment and NRF-2α over-
expression on the transcriptional activity of the rat β-F1 gene,
reporter assays were carried out. To this aim, the construct
pATP5B486, containing the 486 bp fragment (− 503/− 17 bp
upstream the ATG translation initiation codon) of the proximal
promoter region of the rat β-F1 gene, fused to the luciferase
reporter gene, was synthesized. H4IIE cells were transiently co-
transfected with pATP5B486 together with either the pCMV-NRF-
2α or the empty vector pcDNA3.1, then T2 or vehicle was added to
the medium. As a control, a set of transfection experiment with the
empty pGL3-basic vector was carried out. As shown in Fig. 5, T2
treatment of H4IIE cells augmented the β-F1 promoter activity by
approx 80%. NRF-2α overexpression increased promoter activity
with a similar extent. A higher activation (∼130%) of β-F1
promoter was observed in H4IIE cells transfected with pCMV-
NRF2α and cultured in the presence of T2. Neither NRF-2α
overexpression nor T2 treatment caused a signiﬁcant increment of
luciferase activity in H4IIE cells transfected with the empty pGL3-
basic control plasmid.4. Discussion
It has been reported that THs directly inﬂuence the mitochondrial
phosphorylation process by modulating the phosphorylation machin-
ery rather than the respiratory chain [20,21].
While until a few years ago only T4 and T3 were considered the
only active thyroid hormones, evidence has also been reported on
the biological action of T2 [2-5]. The effect of T2 is not restricted to
mammalian species since mitochondrial energy metabolism in liver
and muscle of the goldﬁsh is altered by T2 treatment [36]. It has
been proposed that T2 is able to increase the mitochondrial
respiration rate with a mechanism of action different from that of
T3 [11]. T3 exerts its “long-term” effects mainly controlling the rate
of transcription of genes encoding for different proteins of cellular
energy metabolism [34,37]. T2 effects, unlike those of T3, are often
reported as protein synthesis-independent and they are more rapid
than those of T3 [5].
The direct action of T2 on mitochondria is supported by ﬁndings of
speciﬁc binding sites for T2 in subunit Va of COX. On the other hand, it
has been indicated that the mitochondrial phosphorylation system is
not primarily affected by acute T2 administration [38].
The present ﬁndings, with T2 chronically administered to hypo-
thyroid rats, clearly indicate that T2, besides the increase in oxygen
consumption, signiﬁcantly affects FoF1-ATP synthase activity in liver
mitochondria.
Fig. 4. Effects of T2 on mRNA abundance, protein level and binding to β-F1 promoter of NRF-2 α-subunit in liver from hypothyroid rats. (A) The histogram represents NRF-2 α-
subunit mRNA abundance, determined by using qRT-PCR and expressed as relative amounts (glyceraldehydes-3-phosphate dehydrogenase as a reference) in liver from euthyroid,
hypothyroid and hypothyroid+T2 rats. Data are expressed as percentage of NRF-2 α-subunit mRNA abundance of euthyroid rats (100%) and are means±SE of 4 different
experiments. (B) Total proteins from liver (50 μg), isolated from different rat groups, were separated by electrophoresis, transferred onto nitrocellulose membranes and
immunoblotted using anti-NRF-2 α-subunit antibody. The histogram shows the means±SE of the values obtained from densitometric analysis of 3 different experiments. The data
are expressed as percentage of the protein level of euthyroid rats (100%). (C) Time course of NRF-2α and β-F1 mRNA induction in the liver of hypothyroid rats after T2 treatment.
Hypothyroid rats were injected with a single dose of T2 and killed at the indicated times. Normalized value of β-F1 and NRF-2α transcript levels were reported as percentage of
corresponding values determined in hypothyroid rats at time 0 (arrow). Data are from one of three independent experiments carried out with similar results. (D) In vivo chromatin
immunoprecipitation assay was performed using liver from euthyroid, hypothyroid and T2-treated hypothyroid rats. Results were quantiﬁed by densitometric analysis of the PCR
products separated on agarose gels (data not shown). The values were derived from the average density of the PCR products from hypothyroid or T2-treated hypothyroid rats,
compared with the average density of those from euthyroid rats (100%). Values sharing a different letter differ signiﬁcantly.
238 R. Mangiullo et al. / Biochimica et Biophysica Acta 1797 (2010) 233–240We can reasonably exclude the possibility that the observed effects
exerted by the injected T2 could be attributed to its metabolic
products. The experimental design (PTU+IOP administration) we
used, basically the same as that employed in Goglia's laboratory [3,14],is of advantage in allowing the observed effects to be directly
attributed to the iodothyronine actually administered.
The present work shows that chronic T2 administration to
hypothyroid rats resulted in an increased amount of several
Fig. 5. Effects of T2 and NRF-2α overexpression on β-F1 promoter activity in H4IIE cells.
H4IIE cells were transiently co-transfected with pATP5B486, pGL3 basic empty vector,
and pCMV-NRF2α. After transfection, cells were incubated in DMEM medium with or
without T2 for 24 h. Normalized luciferase activity was expressed as percentage of value
obtained in the control cells, which were transfected with the empty control vector
pcDNA3.1 and incubated without T2 hormone. Values are means±S.E., n=4.
239R. Mangiullo et al. / Biochimica et Biophysica Acta 1797 (2010) 233–240fundamental subunits (i.e. α, β, FoI-PVP and OSCP) of the FoF1-ATP
synthase (Fig. 3). In addition, our results show that the catalytic β-
subunit mRNA abundance increased upon chronic T2 treatment
(Fig. 2). Therefore, the T2-induced enhancement of the β-subunit ex-
pression suggests a T2-mediated nuclear effect. This ﬁnding is in some
waysurprisingas it has been shown thatT2 has substantially lowafﬁnity
for all nuclear thyroid receptor (TRα1, TRα2, TRβ1, TRβ2) [2]. Thus, to
clarify this incongruity and to investigate the molecular mechanism of
T2 effect onβ-F1 expression,we analyzed the induction of the NRF-2α, a
nuclear transcription factor ubiquitously expressed and involved in a
broad rangeof cellular processes, suchas the activationof somenuclear-
encodedmitochondrial genes.NRF-2 is unique amongETS factors family
members because it is an obligate multimeric protein complex [39,40].
It consists of two distinct proteins (NRF-2α and NRF-2β) which form a
tetrameric α2β2 complex. Between the two subunits, only NRF-2α has
been shown to be implicated in the T3-induced up-regulation of β-F1
gene [22]. Our data clearly indicate that T2 signiﬁcantly increased NRF-
2αprotein level andmRNAabundance (Fig. 4A andB). The latterﬁnding
was further supported by the time course experiments, indicating a
rapid and strong increment of NRF-2α-subunit mRNA abundance in
response to T2 injection. β-F1mRNA content also increased and reached
the maximum later than NRF-2 α-subunit mRNA (Fig. 4C). Therefore,
the T2-mediated induction of NRF-2α preceded that of β-F1 subunit,
suggesting that NRF-2 might be involved in the modulation of the
control β-F1 gene by T2. To note that similar results have been reported
after T3 injection [22].
Since NRF-2 has the DNA binding domain located in the α-subunit
and the transcriptional activation domain in the β-subunit, ChIP assay
was conducted using antibody against NRF-2α. ChIP assay results (Fig.
4D) support the hypothesis that T2 up-regulates β-F1 gene expression
not only augmenting mRNA and protein contents of the speciﬁc
transcription factor NRF-2α, but also increasing its binding to β-F1
promoter.
Reporter assay demonstrated that β-F1 promoter activity was
stimulated in transfected H4IIE cells by both T2 treatment and NRF-2α
overexpression (Fig. 5). To note that a higher stimulation of β-F1
promoter has been observed in H4IIE cells transfected with NRF-2α
construct (pCMV-NRF-2α) and cultured in T2-supplemented medium
(Fig. 5). Taken together, these data suggest that T2 could activate NRF-2α not only increasing its mRNA abundance (Fig. 4C) but probably
also through a post-translational modiﬁcation of the protein.
However, we cannot rule out that besides NRF-2α, other transcription
factors might be implicated in T2-mediated induction of β-F1
expression. Further experiments would give more insights into the
role of T2 on β-F1 expression.
Our results on T2-induced stimulation of the transcription rate of
FoF1-ATP synthase can be related to the ﬁnding that in vivo T2
administration augmented mRNA abundance for malic enzyme in rat
liver [2]. T2 was also effective in stimulating growth hormone (GH)
mRNA level in GH3 cells, even if T2 was 100 fold less potent than T3 [2].
On the other hand, down-regulation of TRβ2 mRNA was similar for
both iodothyronines [2]. The common opinion that T2 action is often
associated with its “short-term” effects [5] could be ascribed to the
fact that only few studies so far have been reported on chronic T2
treatment of animals. It has been hypothesized that, because of the
poor permeability of plasma membrane for iodothyronines, only after
chronic treatment of hypothyroid animals it is possible to show an
effect of T2 in some tissues such as the liver [41]. So far, the physio-
pathological role of T2 is not completely deﬁned. The results here
reported on FoF1-ATP synthase activity and expression strongly
support the hypothesis that T2 might be important in physiological
situations requiring additional energy expenditure, such as exposure
to cold [5]. It has been reported [42] that conditions in which a “low T3
state” occurs, such as a nonthyroidal illness and brain tumors, are
characterized by higher T2 concentrations. This phenomenon may
represent a compensatory/defense mechanism activated to maintain
a metabolic-clinical euthyroidism in patients with reduced T3 levels
[42].
Overall, our results represent the ﬁrst evidence that the FoF1-ATP
synthase activity and expression is up-regulated in liver by chronic T2
administration to hypothyroid rats. Our data support the notion that
T2-transcriptional activation of ATP synthase is indirect, being the
nuclear-mediated T2-effects exerted, at least in part, through the
activation of NRF-2α. However, it is worth to underline that our
ﬁndings might be speciﬁc for the liver and, at the moment, they
cannot be simply extended to other tissue.
The present study [see also 5,7, 10–15] provides further evidence
of thyromimetic activity of T2, raising doubts on the uniqueness of T3
as the only active thyroid hormone.
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